At Life Extension, both raw materials and finished products pass through independent testing labs to ensure quality, potency, and purity
Reduction in major cardiovascular events (SELECT trial, semaglutide) Reduced risk of progressing from prediabetes to type 2 diabetes (Tirzepatide, 3yr trial) Weight reduction significantly improves sleep apnea severity confirmed in multiple GLP-1 trials Emerging ADA 2026 data on GLP-1 anti-inflammatory effects and osteoarthritis improvement Improved basal metabolic rate and energy utilisation, especially with tirzepatides GIP pathway We believe cost transparency is part of quality care
Older laser technologies \u201cstamped\u201d the skin, using a grid of lasers that were manually aligned to fractionally treat the skin
Typical side effects are gastrointestinal and usually temporary
Question: Are there any side effects to using compounded sublingual GLP-1 medications
This protective association persisted at two years, with a risk of 1.15% in the GLP-1 group compared to 1.39% in the control group (HR: 0.86)